Becton, Dickinson and Company (VIE:BDX)

Market Cap	49.80B -25.5%
Revenue (ttm)	18.61B +8.2%
Net Income	1.43B -1.6%
EPS	4.96 -0.7%
Shares Out	n/a
PE Ratio	34.82
Forward PE	13.91
Dividend	3.66 (2.16%)
Ex-Dividend Date	Dec 8, 2025

Volume	n/a
Average Volume	1
Open	175.10
Previous Close	174.40
Day's Range	175.05 - 175.95
52-Week Range	141.45 - 242.90
Beta	n/a
RSI	55.53
Earnings Date	Feb 9, 2026

About VIE:BDX

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, va...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1897
• Employees: 72,000
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: BDX

Financial Performance

In fiscal year 2025, VIE:BDX's revenue was $21.84 billion, an increase of 8.24% compared to the previous year's $20.18 billion. Earnings were $1.68 billion, a decrease of -1.58%.

Financial numbers in USD